berbamine has been researched along with 2019 Novel Coronavirus Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhat, S; Chandra, S; Joshi, T; Pundir, H | 1 |
| Cloherty, APM; Ennis, S; Jean, F; Muncan, V; Niikura, M; Patel, KS; Pérez-Vargas, J; Rader, AG; Ribeiro, CMS; Schreurs, RRCE; Thompson, CAH; Wildenberg, ME | 1 |
| Chu, H; Huang, L; Liu, S; Ye, Z; Yue, J; Yuen, TT; Zhang, G | 1 |
| Byun, SY; Choi, I; Jeon, S; Kim, S; Ko, M; Lee, J; Park, S; Shum, D | 1 |
4 other study(ies) available for berbamine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Identification of Berbamine, Oxyacanthine and Rutin from Berberis asiatica as anti-SARS-CoV-2 compounds: An in silico study.
Topics: Benzylisoquinolines; Berberis; COVID-19; Humans; Isoquinolines; Molecular Docking Simulation; Molecular Dynamics Simulation; Protease Inhibitors; Rutin; SARS-CoV-2 | 2021 |
Berbamine suppresses intestinal SARS-CoV-2 infection via a BNIP3-dependent autophagy blockade.
Topics: Antibodies, Neutralizing; Antibodies, Viral; Antiviral Agents; Autophagy; COVID-19; Hepatitis C, Chronic; Humans; Membrane Proteins; Post-Acute COVID-19 Syndrome; RNA, Viral; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2023 |
Berbamine inhibits SARS-CoV-2 infection by compromising TRPMLs-mediated endolysosomal trafficking of ACE2.
Topics: Angiotensin-Converting Enzyme 2; Benzylisoquinolines; COVID-19; COVID-19 Drug Treatment; Endosomes; HEK293 Cells; Humans; Lysosomes; Protein Transport; SARS-CoV-2 | 2021 |
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Niclosamide; Pandemics; Pneumonia, Viral; Pregnenediones; SARS-CoV-2; Vero Cells | 2020 |